Customer concentration and high interest expenses are likely to impact CCI's Q3 results despite its unmatched portfolio of ...
Anticipation surrounds Crown Castle's announcement, with investors hoping to hear about both surpassing estimates and ...
Interestingly, had those agreements been implemented, YRF’s 2025 releases, Saiyaara and War 2, could have enjoyed VPF-free ...
Crown Castle (CCI) delivered FFO and revenue surprises of +7.69% and +1.98%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Detailed price information for Crown Castle Inc (CCI-N) from The Globe and Mail including charting and trades.
This will be the second biggest deal in the pharma sector ever after Sun Pharmaceutical Industries’ 2015 acquisition of ...
CCI approves Torrent Pharma''s acquisition of JB Chemicals stake after modifications. Deal to create India''s second-largest ...